Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics

European Journal of Surgical Oncology

Volumn 41, Issue 10, 2015, Pages 1417-1422

  Hofvind, S ^a,b   Holen, Å ^a   Aas, T ^c   Roman, M ^a,d   Sebuodegard S ^a   Akslen, L A ^c,e  

^a CANCER REGISTRY OF NORWAY   (Norway)

^b OSLO METROPOLITAN UNIVERSITY   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF BERGEN   (Norway)

Author keywords

Breast cancer; Prognosis; Surgical treatment; Survival

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER HORMONE THERAPY; CANCER PROGNOSIS; CANCER RISK; COMPARATIVE STUDY; DISEASE SPECIFIC SURVIVAL; DYING; FEMALE; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MASTECTOMY; NORWAY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; TUMOR VOLUME; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; BREAST NEOPLASMS; CANCER STAGING; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; COHORT ANALYSIS; EARLY DIAGNOSIS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SEGMENTAL MASTECTOMY; SURVIVAL RATE;

AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR BURDEN;

EID: 84943815486     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2015.07.002     Document Type: Article

References (27)

1. A. Goldhirsch, E.P. Winer, A.S. Coates, and et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 Ann Oncol - Off J Eur Soc Med Oncol/ESMO 24 9 2013 2206 2223
2. B. Fisher, J.H. Jeong, S. Anderson, J. Bryant, E.R. Fisher, and N. Wolmark Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation N Engl J Med 347 8 2002 567 575
3. S. Zurrida, and U. Veronesi Milestones in breast cancer treatment Breast J 21 1 2015 3 12
4. U. Veronesi, N. Cascinelli, L. Mariani, and et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer N Engl J Med 347 16 2002 1227 1232
5. R.A. Freedman, Y. He, E.P. Winer, and N.L. Keating Trends in racial and age disparities in definitive local therapy of early-stage breast cancer J Clin Oncol - Off J Am Soc Clin Oncol 27 5 2009 713 719
6. C.A. Garcia-Etienne, M. Tomatis, J. Heil, and et al. Mastectomy trends for early-stage breast cancer: a report from the EUSOMA multi-institutional European database Eur J Cancer (Oxford, England: 1990) 48 13 2012 1947 1956
7. E.S. Hwang, D.Y. Lichtensztajn, S.L. Gomez, B. Fowble, and C.A. Clarke Survival after lumpectomy and mastectomy for early stage invasive breast cancer Cancer 119 7 2013 1402 1411
8. S. Hofvind, E. Schlichting, G. Ursin, S. Sebuodegard, and R. Karesen Breast cancer surgery in Norway 1986-2009 Tidsskrift for den Norske laegeforening: tidsskrift for praktisk medicin, ny raekke 133 15 2013 1582 1586
9. K.L. Kummerow, L. Du, D.F. Penson, Y. Shyr, and M.A. Hooks Nationwide trends in mastectomy for early-stage breast cancer JAMA Surg 150 1 2015 9 16
10. S.B. Hwang, J.W. Bae, H.Y. Lee, and H.Y. Kim Circulating tumor cells detected by RT-PCR for CK-20 before surgery indicate Worse prognostic Impact in Triple-negative and HER2 subtype breast cancer J Breast Cancer 15 1 2012 34 42
11. M.A. Martin, R. Meyricke, T. O'Neill, and S. Roberts Breast-conserving surgery versus mastectomy for survival from breast cancer: the Western Australian experience Ann Surg Oncol 14 1 2007 157 164
12. S. Agarwal, L. Pappas, L. Neumayer, K. Kokeny, and J. Agarwal Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer JAMA Surg 149 3 2014 267 274
13. O.J. Hartmann-Johnsen, R. Karesen, E. Schlichting, and J.F. Nygard Survival is better after breast conserving therapy than mastectomy for early stage breast cancer: a registry-based follow-up study of norwegian women primary operated between 1998 and 2008 Ann Surg Oncol 2015 Mar 6 [Epub ahead of print]
14. I.K. Larsen, M. Smastuen, T.B. Johannesen, and et al. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness Eur J Cancer (Oxford, England: 1990) 45 7 2009 1218 1231
15. S. Hofvind, B. Geller, P.M. Vacek, S. Thoresen, and P. Skaane Using the European guidelines to evaluate the Norwegian breast cancer screening program Eur J Epidemiol 22 7 2007 447 455
16. S.W. Duffy, I.D. Nagtegaal, M. Wallis, and et al. Correcting for lead time and length bias in estimating the effect of screen detection on cancer survival Am J Epidemiol 168 1 2008 98 104
17. S. Litière, G. Werutsky, I.S. Fentiman, and et al. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial Lancet Oncol 13 4 2012 412 419
18. J.A. van Dongen, A.C. Voogd, I.S. Fentiman, and et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial J Natl Cancer Inst 92 14 2000 1143 1150
19. S.W. Duffy, L. Tabar, G. Fagerberg, and et al. Breast screening, prognostic factors and survival-results from the Swedish two county study Br J Cancer 64 6 1991 1133 1138
20. Y. Shen, Y. Yang, L.Y. Inoue, M.F. Munsell, A.B. Miller, and D.A. Berry Role of detection method in predicting breast cancer survival: analysis of randomized screening trials J Natl Cancer Inst 97 16 2005 1195 1203
21. H. Joensuu, T. Lehtimaki, K. Holli, and et al. Risk for distant recurrence of breast cancer detected by mammography screening or other methods JAMA 292 9 2004 1064 1073
22. K. Collett, I.M. Stefansson, J. Eide, and et al. A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors Cancer Epidemiol Biomarkers Prev - Publ Am Assoc Cancer Res Cosponsored by Am Soc Prev Oncol 14 5 2005 1108 1112
23. M. Kalager, T. Haldorsen, M. Bretthauer, G. Hoff, S.O. Thoresen, and H.O. Adami Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study Breast Cancer Res - BCR 11 4 2009 R44
24. S.W. Duffy, H.H. Chen, L. Tabar, and N.E. Day Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase Statistics Med 14 14 1995 1531 1543
25. H. Weedon-Fekjaer, B.H. Lindqvist, L.J. Vatten, O.O. Aalen, and S. Tretli Estimating mean sojourn time and screening sensitivity using questionnaire data on time since previous screening J Med Screen 15 2 2008 83 90
26. Guidelines for treatment of women with breast cancer in Norway: http://nbcg.no/retningslinjer/ Cited July 13, 2015.
27. L. Tabar, S.W. Duffy, B. Vitak, H.H. Chen, and T.C. Prevost The natural history of breast carcinoma: what have we learned from screening? Cancer 86 3 1999 449 462